The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States.

Barnett, P G; Zaric, G S; Brandeau, M L

Barnett, P G; Zaric, G S; Brandeau, M L.

Affiliation

Barnett PG; Health Economics Resource Center, Veterans Affairs Palo Alto Health Care System, Menlo Park, CA, USA and the Department of Health Research and Policy, Stanford University, Stanford, CA, USA. paul.barnett@med.va.gov

Addiction ; 96(9): 1267-78, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11672491

Subject(s)

Buprenorphine/therapeutic use; Narcotic Antagonists/therapeutic use; Opioid-Related Disorders/economics; Buprenorphine/economics; Cost-Benefit Analysis; Humans; Narcotic Antagonists/economics; Opioid-Related Disorders/rehabilitation; Quality-Adjusted Life Years; United States

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Narcotic Antagonists / Opioid-Related Disorders Type of study: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte Language: En Journal: Addiction Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2001 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links